MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202647023637 A) filed by Wu, Nian, New Brunswick, U.S.A., on Feb. 27, for 'pharmaceutical compositions comprising antiviral agents and optionally steviol glycosides.'
Inventor(s) include Wu, Nian.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The disclosure in one aspect provides a pharmaceutical composition of an antiviral agent, the pharmaceutical composition comprising: the antiviral agent, which can be tenofovir; and a PEG-saccharide-lipid conjugate having the structural formula wherein m has a number-average value in the range of 2-10; S is a mono-, di- or trisaccharide group; L is -C(O)-R1 in which R1 is an alkanyl or alkenyl group having a number- average number of carbons in the range of 6-22, and/or is a steroid acyl group; P is -(CH2-CH2-O)nR2 in which n has a number-average value in the range of 5-50 and R2 is hydrogen and/or alkanyl and has a number average number of carbons in the range 0-4. Such compositions can be provided in a variety of forms. In various such embodiments, the pharmaceutical composition further includes one or more steviol glycosides mainly comprising one or more steviosides and/or rebaudiosides."
The patent application was internationally filed on July 29, 2024, under International application No.PCT/US2024/040092.
Disclaimer: Curated by HT Syndication.
